Carlos Hermosilla Selected Research

Carlos Hermosilla Research Topics

Disease

20	Infections 03/2021 - 04/2006
4	Coccidiosis 09/2020 - 06/2012
2	Cryptosporidiosis 06/2022 - 03/2020
2	Acidosis 01/2021 - 01/2017
2	Communicable Diseases (Infectious Diseases) 12/2020 - 01/2020
2	Parasitic Diseases (Parasitic Disease) 01/2019 - 01/2019
1	Adenocarcinoma 06/2022
1	Hyperoxia 01/2021
1	Inflammation (Inflammations) 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Toxoplasmosis 09/2020
1	Mastitis 01/2020
1	Metabolic Bone Diseases (Osteopenia) 06/2018
1	Nephrosis 06/2018
1	Nephritis 06/2018
1	Reinfection 02/2010
1	Eosinophilia 06/2006
1	Weight Loss (Weight Reduction) 06/2006
1	Weight Gain 06/2006

Drug/Important Bio-Agent (IBA)

3	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 06/2022 - 10/2016
2	CytokinesIBA 01/2021 - 08/2015
2	LipidsIBA 09/2020 - 01/2019
2	VaccinesIBA 09/2020 - 01/2014
2	carbol-fuchsin solutionIBA 03/2020 - 01/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2015 - 12/2006
2	AntigensIBA 02/2010 - 12/2008
1	octaarginineIBA 06/2022
1	nitazoxanide (NTZ)FDA Link 06/2022
1	valspodar (PSC 833)IBA 03/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	CarbohydratesIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	HeterochromatinIBA 01/2021
1	PyruvatesIBA 01/2021
1	Platelet Activating FactorIBA 12/2020
1	Linoleic Acid (Linoleate)IBA 01/2020
1	Oleic Acid (Oleate)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 10/2019
1	Histones (Histone)IBA 10/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	CholesterolIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	Cyclin B1IBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	CalciumIBA 06/2018
1	CurcuminIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 04/2017
1	Secretory Immunoglobulin A (SIgA)IBA 04/2017
1	Immunoglobulin G (IgG)IBA 04/2017
1	Immunoglobulin M (IgM)IBA 04/2017
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2017
1	Syntex adjuvant formulationIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Sodium Acetate (Sodium Acetate, Anhydrous)FDA LinkGeneric 01/2016
1	Methanol (Carbinol)IBA 01/2016
1	ChemokinesIBA 08/2015
1	AnthelminticsIBA 03/2014
1	diclazurilIBA 06/2012
1	Cytochromes c (Cytochrome c)IBA 03/2009
1	Caspase 3 (Caspase-3)IBA 03/2009
1	PhosphatidylserinesIBA 03/2009
1	phorbolIBA 12/2008
1	Acetates (Acetic Acid Esters)FDA Link 12/2008
1	Interleukin-2 (IL2)IBA 12/2008
1	IonomycinIBA 12/2008
1	Interleukin-4 (Interleukin 4)IBA 12/2008
1	Myristic Acid (Tetradecanoic Acid)IBA 12/2008
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 03/2008
1	Interleukin-8 (Interleukin 8)IBA 12/2006
1	Chemokine CCL5IBA 12/2006
1	Messenger RNA (mRNA)IBA 12/2006
1	CC ChemokinesIBA 12/2006
1	CXC ChemokinesIBA 12/2006
1	moxidectinIBA 06/2006
1	FenbendazoleIBA 06/2006
1	Blood Proteins (Serum Proteins)IBA 06/2006
1	GlobulinsIBA 06/2006
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2006
1	P-SelectinIBA 04/2006
1	E-SelectinIBA 04/2006

Therapy/Procedure

1	Therapeutics 04/2019
1	Lasers (Laser) 03/2008